What is the Difference Between IL-2 and IL-15?
🆚 Go to Comparative Table 🆚IL-2 and IL-15 are both cytokines that play critical roles in the immune system, but they have distinct functions and mechanisms of action. Some key differences between IL-2 and IL-15 include:
- Receptors: Both IL-2 and IL-15 have heterotrimeric receptors with a common cytokine receptor subunit, γc (also known as IL-2Rγ or CD132), and a shared beta subunit, IL-2/15Rβ (also known as CD122). However, they have unique alpha chains, IL-2Rα and IL-15Rα, respectively, which could contribute to their distinct physiological effects.
- Synthesis and Secretion: IL-2 is predominantly a secreted cytokine, while IL-15 is a membrane-associated molecule. IL-2 is produced by activated T cells, and its expression is regulated at the transcriptional level. In contrast, IL-15 expression is controlled by multiple negative regulatory elements, including a long 5' UTR containing IL-13 upstream AUGs, an unusually long signal peptide, and an inhibitory element in the C terminus of the IL-15 mature coding sequence or protein.
- Cellular Effects: IL-2 usually favors the rapid proliferation of short-lived effector cells, while IL-15 supports the maintenance of long-lived memory cells. IL-15 stimulates the persistence of memory phenotype CD8+ T cells, whereas IL-2 inhibits their expression.
- Different Signaling Kinetics: IL-2 binds as a soluble ligand, whereas IL-15 is thought to be presented in trans by the IL-15Rα subunit to β/γ subunits on responding cells. IL-2 signaling is sustained because IL-2 up-regulates the expression of its α subunit, which replenishes surface levels of high-affinity IL-2 receptors. In contrast, IL-15 signaling is relatively transient, and IL-15Rα chain expression is not maintained in the presence of IL-15.
These differences in receptors, synthesis, cellular effects, and signaling kinetics contribute to the distinct roles of IL-2 and IL-15 in the immune system and their potential applications in cancer immunotherapy and other therapeutic settings.
Comparative Table: IL-2 vs IL-15
IL-2 and IL-15 are both interleukins in the immune system that play crucial roles in regulating T and NK cell functions. They share common receptor components and the JAK/STAT signaling pathway. However, there are several differences between them:
Feature | IL-2 | IL-15 |
---|---|---|
Production | Mainly produced by activated CD4 Th1 cells | Expressed in various tissues, including keratinocytes and nerve cells |
Form | Predominantly a secreted cytokine | Membrane-associated molecule |
Receptor | Uses IL-2Rα and IL-2Rβ as receptor subunits | Uses IL-15Rα and IL-2/15Rβ as receptor subunits |
Function | Stimulates activated T cell proliferation, generates cytotoxic effector T cells, and activates NK cells | Shares similar functions with IL-2, but its signals do not overlap with IL-2 signals |
roles in cancer therapy | Used in the treatment of cancer | Recent data suggest IL-2 and IL-15 differ in their ability to activate T and NK cells to resist various forms of immune suppression |
Despite their similarities, IL-2 and IL-15 signals differ in magnitude, timing, and context. While IL-2 binds its receptor as a soluble molecule, IL-15 is presented by IL-15Rα in trans to neighboring cells. Their distinct physiological distribution and receptor usage contribute to their unique roles in the immune system and potential applications in cancer immunotherapy.
- Interleukin 1 vs 2
- Cytokines vs Interleukins
- IGF1 vs IGF2
- Lymphokines vs Cytokines
- Type I vs Type II Interferon
- Cytokines vs Interferons
- Cytokines vs Chemokines
- Cytokines vs Hormones
- T Lymphocytes vs B Lymphocytes
- TH1 vs TH2 Helper Cells
- HIF-1 vs HIF-2
- T Cells vs B Cells
- Interferon Alpha 2A vs 2B
- Intracellular vs Intercellular Signaling
- IgG vs IgE
- Leukemia vs Lymphoma
- Mitogen vs Growth Factor
- Lymphocytes vs Leucocytes
- CTLA-4 vs PD-1